Stock 2096 SIMCERE PHARMACEUTICAL GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Simcere Pharmaceutical Group Limited

Equities

2096

HK0000658531

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:09:13 2024-04-23 am EDT 		5-day change 1st Jan Change
5.22 HKD +0.19% Intraday chart for Simcere Pharmaceutical Group Limited +1.95% -22.44%
Apr. 10 Simcere Pharmaceutical's Cancer Drug Gets Fast Track Designation From US FDA MT
Apr. 09 Simcere Pharmaceutical Group Limited Announces SIM0500 for Injection (a Humanized GPRC5D-BCMA-CD3 Trispecific Antibody) Receives Fast Track Designation by the U.S. Food and Drug Administration CI

Business Summary

Simcere Pharmaceutical Group Ltd is a company engaged in research and development, production and sales of drugs. The Company's main products are generic drugs, including Bicun used for central nervous system diseases, Jepaso and Jiebaili used for oncology, as well as Yingtaiqing used for autoimmune diseases. The Company also produces innovative drugs, such as Endostar used for oncology. The Company is also involved in providing promotion services for third-party drugs sold by medical institutions.

Number of employees: 7,027

Sales per Business

HKD in Million2021Weight2022Weight Delta
Nervous System
35.9 %
1,860 30.9 % 2,636 35.9 % +41.76%
Oncology
22.6 %
1,446 24.0 % 1,663 22.6 % +14.98%
Other
21.2 %
1,155 19.2 % 1,561 21.2 % +35.16%
Autoimmune
20.3 %
1,075 17.8 % 1,488 20.3 % +38.46%

Sales per region

HKD in Million2021Weight2022Weight Delta
China
100.0 %
6,026 100.0 % 7,348 100.0 % +21.95%

Managers

Managers TitleAgeSince
Jin Sheng Ren CEO
 Chief Executive Officer 61 94-12-31
Yu Shan Wan DFI
 Director of Finance/CFO 53 00-04-30
Gaobo Zhou CIO
 Chief Investment Officer 45 22-01-16
Mookerjee Bijoyesh CTO
 Chief Tech/Sci/R&D Officer 62 22-01-31
Pin Wang CTO
 Chief Tech/Sci/R&D Officer 49 19-08-31
Peng Wang CTO
 Chief Tech/Sci/R&D Officer 65 08-12-31
Xi Wang BRD
 Director/Board Member 41 20-04-30
Ren Hong Tang BRD
 Director/Board Member 44 19-04-30
Ying Guo IRC
 Investor Relations Contact - -
Danny Chen PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Jin Sheng Ren CEO
 Chief Executive Officer 61 94-12-31
Xin Hua Wang BRD
 Director/Board Member 69 19-11-18
Yu Shan Wan DFI
 Director of Finance/CFO 53 00-04-30
Rui Lin Song BRD
 Director/Board Member 61 19-11-18
Jian Guo Wang BRD
 Director/Board Member 64 19-11-18
Ren Hong Tang BRD
 Director/Board Member 44 19-04-30
Ka Woon Sung BRD
 Director/Board Member 53 23-01-17
Xi Wang BRD
 Director/Board Member 41 20-04-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,609,761,618 749,085,004 ( 28.70 %) 0 28.70 %

Shareholders

NameEquities%Valuation
Simcere Holding Ltd.
36.42 %
950,431,689 36.42 % 645 M $
New Good Management Ltd.
23.25 %
606,810,031 23.25 % 412 M $
Jin Sheng Ren
9.372 %
244,586,948 9.372 % 166 M $
Fortune Fountain Investment Ltd.
4.635 %
120,961,370 4.635 % 82 M $
Exponential Fortune Group Ltd.
2.142 %
55,905,613 2.142 % 38 M $
China Southern Asset Management Co., Ltd.
1.767 %
46,124,000 1.767 % 31 M $
Fullgoal Fund Management Co., Ltd.
0.7962 %
20,778,000 0.7962 % 14 M $
Essence Fund Co., Ltd.
0.5646 %
14,736,000 0.5646 % 10 M $
Principal Global Investors (Hong Kong) Ltd.
0.5409 %
14,117,000 0.5409 % 10 M $
China Asset Management Co., Ltd.
0.3851 %
10,051,000 0.3851 % 7 M $

Holdings

NameEquities%Valuation
3D MEDICINES INC.
8.93%
 23,047,468 8.93% 17,757,152 $

Company contact information

Simcere Pharmaceutical Group Ltd.

No. 699-18 Xuan Wu Avenue Xuan Wu District

210042, Nanjing

+86 25 8556 6666

http://www.simcere.com
address Simcere Pharmaceutical Group Limited(2096)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Ratings for Simcere Pharmaceutical Group Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
4.816 CNY
Average target price
7.984 CNY
Spread / Average Target
+65.77%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

1st Jan change Capi.
SIMCERE PHARMACEUTICAL GROUP LIMITED Stock Simcere Pharmaceutical Group Limited
-22.44% 1.71B
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+18.54% 44.31B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+19.87% 22.17B
SANDOZ GROUP AG Stock Sandoz Group AG
+14.75% 14.62B
CIPLA LIMITED Stock Cipla Limited
+9.39% 13.12B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+38.97% 11.58B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.96% 6.96B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+6.50% 5.03B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 2096 Stock
  4. Company Simcere Pharmaceutical Group Limited